Bayer receives approval for EYLEAź in Japan
Bayer has received approval from the Ministry of Health, Labour and Welfare in Japan for EYLEAź (aflibercept solution for injection) for treatment of myopic choroidal neovascularization. In Japan, pathologic myopia and the associated myopic CNV is the second most common cause of blindness. September 22, 2014